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Abstract
Prostaglandins (PG) are effective abortifacients and are important mediators of lipopolisaccharide (LPS)-induced embryonic
resorption (ER). Besides, anandamide (AEA) has been described as one of the major endocannabinoids present in the uterus
suggesting that it might play a role in reproduction. It has been reported that high levels of AEA are associated with
pregnancy failure and that LPS increases AEA production. Also, it has been observed that AEA modulates PG production in
different tissues. In this sense, we studied whether LPS-induced PG production is modulated by AEA and we also assessed
the effect of this endocannabinoid on PG metabolism in an in vitro model. Uterine explants from BALB/c implantation sites
were cultured in the presence of LPS plus cannabinoid receptor (CB) specific antagonists and PG production was assessed.
Then, we studied the effect of exogenous AEA on different steps of PG metabolic pathway. We showed that AEA is involved
in LPS-induced PG biosynthesis. Also, we observed that AEA exerts opposite effects on PGE2 and PGF2a biosynthesis, by
inhibiting PGE2 production and increasing PGF2a levels. We suggest that AEA could be involved in the mechanisms
implicated in LPS-induced ER. A better understanding of how AEA could be affecting ER could help developing specific
interventions to prevent this pathology.
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Introduction
Intrauterine infection plays a major role in the pathogenesis of
early pregnancy loss. It has been reported that Gram-negative
organisms induce preterm labor and embryonic loss by triggering
the release of various proinflammatory molecules, such as
cytokines, growth factors and prostaglandins [1,2,3]. Prostaglan-
dins are important paracrine regulators of uterine function in
normal and pathological pregnancies and are used clinically to
induce abortion and stimulate parturition [4]. Our previous
results [1] showed that in vivo administration of lipopolysaccha-
ride (LPS), a component of Gram-negative bacteria, increased
prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a) pro-
duction in the uterus of early pregnant mice. We have also
observed that, in mice challenge with LPS, the in vivo
administration of cyclooxygenase (COX) inhibitors prevented
LPS-induced embryonic resorption (ER).
Anandamide (arachidonoylethanolamide, AEA) belongs to
a group of endogenous lipids termed ‘‘endocannabinoids’’ [5]
and is an agonist of type-1 (CB1) and type-2 (CB2) cannabinoid
receptors. It has been described as one of the major
endocannabinoids present in the uterus and this suggests that
it might play a role in reproduction [6]. It has been reported
that low levels of AEA are beneficial for implantation and
trophoblast outgrowth while increased AEA concentrations are
associated with retarded embryo development, fetal loss and
pregnancy failure [7]. Previous results indicate that LPS
increases AEA levels in human peripheral lymphocytes [8]
and in murine macrophages [9]. Our previous results suggest
that LPS could be increasing AEA levels in uterine explants by
inhibiting its degradation and also by enhancing NAPE-PLD
expression, one of its synthesizing enzymes [10]. In addition,
recent research has revealed that AEA regulates prostaglandin
production in human gestational tissues, cerebral microvascular
endothelium and in rat pheochromocytoma PC12 cells
[11,12,13]. Although several lines of evidence indicate that
both, cannabinoids and AEA, stimulate arachidonic acid (AA)
release in several tissues [14,15,16], the relationship between
endocannabinoids and PG metabolism is not fully understood.
In the present study we investigated whether LPS-induced PG
production is modulated by AEA and we also determined the
effect of this endocannabinoid on PG biosynthesis and
catabolism in uterine explants from pregnant mice.
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Materials and Methods
Animals
BALB/c 8- to 12-week-old virgin female mice were paired with
8- to 12-week-old BALB/c males and the day of appearance of
a coital plug was taken as day 0 of pregnancy. Animals were
housed in cages under controlled conditions of light (14 h light,
10 h dark) and temperature (23–25uC) and received murine chow
and water ad libitum. Mice were sacrificed by cervical dislocation
on day 7 of pregnancy and in each implantation site the uterus and
the decidua were separated. Uterine explants (composed of
myometrial cells and uterine adventitia) were weighed and culture
as described below.
Ethics Statement
The experimental procedures reported here were approved by
the Animal Care Committee of the Center for Pharmacological
and Botanical Studies of the National Research Council
(CEFYBO - CONICET) and were carried out in accordance
with the Guide for Care and Use of Laboratory Animals (NIH).
Culture of Uterine Explants from Implantation Sites
We established the optimal culture conditions in a previous
work [10]. Briefly, uterine explants were weighed and cultured in
wells that contained DMEM supplemented with 10% FCS and
1% antibiotic-antimycotic solution. Tissues were maintained for
24 h in 5% CO2 in air at 37uC and then culture supernatants and
explants were immediately frozen at –70uC until use.
Figure 1. LPS-induced PGE2 and PGF2a production is mediated by endocannabinoids. A) PGE2 production for uterine explants incubated
with LPS (1 ug/ml) and AM251 (10 nM) or SR144528 (10 nM) for 24 h. ANOVA test. a, p,0.001 vs control or AM251 or SR144528; b, p,0.001 vs
control or AM251; c, p,0.001 vs LPS. n = 6. B) PGF2a production for uterine explants incubated with LPS (1 ug/ml) and AM251 (10 nM) or SR144528
(100 nM) for 24 h. ANOVA test. a, p,0.001 vs control or AM251 or SR144528; b, p,0.01 vs control or AM251; c, p,0.001 vs control or SR144528; d,
p,0.001 vs LPS; e, p,0.01 vs LPS. n = 5.
doi:10.1371/journal.pone.0039532.g001
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Reverse Transcription Polymerase Chain Reaction (RT-
PCR) Analysis
cDNA was synthesized from total RNA as described by Vercelli
et al. [10]. Oligonucleotide primers for COX-1, COX-2 and b-
actin were synthesized as described by Aisemberg et al. [1] and
PCR cycle parameters were described in the same work.
Oligonucleotide primers for CB1 were 59-ACCTGATGTTCTG-
GATCGGA-39 (forward) and 59-TGTTATCTA-
GAGGCTGCGCA-39 (reverse) and for CB2 were 59-
CCGGAAAAGAGGATGGCAATGAAT-39 (forward) and 59-
CTGCTGAGCGCC CTGGAGAAC-39 (reverse). Oligonucleo-
tide primers for mPGES-1, mPGES-2 and cPGES were
synthesized using Primer 3 Input free Software (v 0.4.0) [17].
For mPGES-1, 59-GGGTCCCAGGAATGAGTACA-39 (for-
ward) and 59-TTTCTGCTCTGCAGCACACT-39 (reverse) were
used; for mPGES-2, 59-CAGGTACCAAGGCTGGATGT-39
(forward) and 59-CACCTGCAGGATGATGTACG-39 (reverse)
were used; and for cPGES, 59-AAAATCCAGGCGATGACAAC-
39 (forward) and 59-TTGGAAAGACTGGGAGGATG-39 (re-
verse) were used. PCR products (COX-1, 449 bp; COX-2,
320 bp; b-actin, 392 bp; CB1,450 bp; CB2, 479 bp; mPGES-1,
237 bp; mPGES-2, 201 bp and cPGES, 194 bp) were separated
on 1.5% agarose gel, stained with ethidium bromide, recorded
under UV light with a digital camera Olympus C-5060 and
analysed using the Image J software package (open source). Data
were expressed as the relative amount of each PCR product versus
b-actin mRNA.
Quantitative Polymerase Chain Reaction (qPCR) Analysis
cDNA was synthesized from total RNA as described by
Vercelli et al. [10]. Real-time quantitative PCR was performed
with a Corbett-Rotor Gene system (Qiagen, Argentina) using
Figure 2. AEA mediates LPS-induced PG production. A) PGE2 production for uterine explants incubated with LPS (1 ug/ml), m-AEA (100 nM),
URB597 (1 uM), LPS plus m-AEA (100 nM) or LPS plus URB597 (1 uM) for 24 h. ANOVA test. a, p,0.001 vs control; b, p,0.01 vs LPS; c, p,0.001 vs LPS.
n = 7. B) PGF2a production for uterine explants incubated with LPS (1 ug/ml), m-AEA (100 nM), URB597 (1 uM), LPS plus m-AEA (100 nM) or LPS plus
URB597 (1 uM) for 24 h. ANOVA test. a, p,0.001 vs control; b, p,0.01 vs LPS; c, p,0.05 vs control; d, p,0.01 vs control. n = 7.
doi:10.1371/journal.pone.0039532.g002
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EVA green (Biotium Inc., CA, USA) as the detection agent.
Oligonucleotide primers for m-PGES-1 and b-actin were
synthesized as described by Kubota et al. [18] and by Wang
et al. [19], respectively. Specificity of the PCR reaction was
controlled by the generation of melting curves. The relative
gene expression levels were calculated using the comparative Ct
(DDCt) method [20]. Data was normalized to b-actin and
mPGES-1 mRNA levels under control conditions (no m-AEA)
were set to 1 (dotted line). Experiments were independently run
three times. In each experiment, cDNA samples were performed
in triplicate.
Western Blot Analysis
Tissues were homogenized and centrifuged as described by
Vercelli et al. [21]. Samples were separated by electrophoresis
and transferred to a nitrocellulose membrane. Blots were
incubated overnight with the primary antibodies and 30 minutes
with anti-b-actin, washed with buffer (10 mM Tris,
100 mM NaCl and 0.1% Tween 20, pH 7.5) followed by 1 h
incubation with horse radish peroxidase-conjugated anti-rabbit
secondary antibody, and developed using the enhanced
chemiluminescence western blot system. Photographs of the
membranes were taken using a digital camera and analysed
using the Image J software package.
PGE2 and PGF2a Determination
The amount of PGE2 and PGF2a were assayed in culture
supernatants by specific radioimmunoassay (RIA) as reported by
Farina et al. [22]. Briefly, specific antisera for both PGF2a and
PGE2 were used. Labelled [
3H]-PGE2 and [
3H]-PGF2a were
added to each tube. The incubation was performed for 90 min
at 4uC. Bound and free radioligands were separated by dextran-
coated charcoal and the tubes were centrifuged for 15 min at
20006g. Results were expressed as pg PG/mg tissue (wet
weight).
Quantification of PGE2 metabolite (PGEM)
PGE2 metabolite was assayed in culture supernatants with the
PGE metabolite EIA kit (catalog No. 14531; Cayman Chemical
Co) according to the manufacturer’s recommendations. PGE2 is
not chemically stable and is rapidly converted to its 13,14-
dihydro-15-keto metabolite. The PGE metabolite assay kit
converts all of the immediate PGE2 metabolites in the
supernatant to a single stable derivative that could be easily
quantified by EIA. PGEM levels are reported as pg PGEM/mg
tissue (wet weight).
Determination of PGE Synthase (PGES) Activity
PGES activity in uterine explants was measured by assess-
ment of conversion of PGH2 to PGE2 as reported by Murakami
et al. [23] with minor modifications. Briefly, tissues were
Figure 3. Effect of LPS on CB1 and CB2 levels. Densitometric analysis and expression of CB1 and CB2. Uterine explants were incubated without/
with LPS (1 ug/ml) for 24 h and where subjected to RT-PCR and western blot analysis. Student t Test. a, p,0.05 vs control. Each gel was repeated
three times with different samples. One representative gel/blot is shown.
doi:10.1371/journal.pone.0039532.g003
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homogenized in a 10 mM Tris-HCl buffer (pH=8) and after
centrifugation the supernatants were used as the enzyme source.
One hundred micrograms of protein were incubated with 2 mg
of PGH2 for 1 min at 24uC in 0.1 ml of 1 M Tris-HCl, pH=8,
containing 2 mM GSH. After terminating the reaction by the
addition of 20 ul of HCl 6N, PGE2 content in the supernatants
was quantified by radioimmunoassay. Results were expressed as
pg PGE2/mg protein/h.
COX-2 Enzyme Activity Determination
COX-2 activity was determined by measuring the disappear-
ance of the radiolabelled substrate [14C]-arachidonic acid using
a modified method previously reported [24]. Briefly, 100 mg of
uterine explants were homogenized in 1 ml cold fresh buffer
(50 mM Tris-HCl and 1 mM EDTA, pH=8), centrifuged at
20000 xg for 60 min at 4uC and supernatant was used for
subsequent determination of enzyme activity. One hundred
micrograms of protein were added to each incubation tube in
Figure 4. LPS-induced COX-2 expression is mediated by endocannabinoids. Densitometric analysis of A) mRNA and B) protein expression
of COXs. Uterine explants were incubated with LPS alone (1 ug/ml), LPS plus AM251 (10 nM) or LPS plus SR144528 (10 nM) for 24 h. A) ANOVA test. a,
p,0.001 vs control; b, p,0.001 vs LPS; c, p,0.01 vs control; d, p,0.05 vs control. n = 5. B) ANOVA test. a, p,0.001 vs control; b, p,0.001 vs LPS;
n = 4. One representative gel/blot is shown.
doi:10.1371/journal.pone.0039532.g004
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cold fresh buffer to a final volume of 100 ul containing 110
000 d.p.m [14C]-arachidonic acid (AA, specific activity 53 mCi/
mmol), either alone or with a selective COX-2 inhibitor (NS-398
1 mM). The sample and substrate mixture with a non-selective
COX inhibitor (Indomethacin, [INDO] 1 mM) was used to
determine the [14C]-AA disappearance values due to other
enzymatic activities (lipoxygenase and/or epoxygenase) and non-
enzymatic reactions [25]. The mixture was then incubated at
37uC for 30 min. Termination was achieved by addition of
chloroform:methanol (1:1, v/v). The unreacted [14C]-AA was
resolved in the organic layer of a solvent system of ethyl
acetate:hexane:acetic acid:distilled water (100:50:20:100 v/v)
mixture. The distribution of radioactivity on the plate was
counted in a scintillation counter by scraping off the correspond-
ing spots detected in the plate. The area of each radioactive peak
corresponding to AA was calculated and expressed as a percent-
age of the total radioactivity of the plates. For each sample,
COX-1 activity was determined by calculating the rate of loss of
[14C]-AA incubated with selective COX-2 inhibitor. Conversely,
the COX-2 activity of each corresponding sample was de-
termined by calculating the rate of loss of [14C]-AA incubated
without selective COX-2 inhibitor, and subtracting from this
value that of COX-1. The values of COX-2 and COX-1 were
corrected by subtracting the [14C]-AA disappearance values due
to other enzymatic activities and non-enzymatic reactions.
Enzyme activity is reported as nmol of disappeared [14C]-AA/
mg protein/h. The optimal reaction conditions were previously
determined (data not shown).
Drugs, Chemical Reagents and Other Materials
LPS from Escherichia coli 05:B55, secondary horse radish
peroxidase (HRP) conjugated antibody, anti-b-actin antibody,
R-(+)-methanandamide, NADPH, and GSH were purchased
from Sigma Chemical Co. (St Louis, MI, USA). AM251 was
purchased from Tocris Cookson Inc. (Ellisville, MO, USA).
SR144528 was kindly provided by Sanofi-Aventis. Indomethacin
was obtained from Laboratorios Montpellier (Bs As, Argentina).
TLC aluminum Silica Gel plates were purchased from Merck
KGaA (Darmstadt, Germany). Western blotting reagents were
obtained from Bio-Rad Laboratory. Anti-COX-1 and anti-COX-
2 antibodies, PGH2, URB597 and Prostaglandin E Metabolite
EIA kit were purchased from Cayman Chemical Co (Ann Arbor,
MI, USA).The anti-mPGES-1 antibody was obtained from BD
Biosciences (Franklin Lakes, NJ, USA). All other chemicals were
analytical grade.
Data Analysis and Statistical Procedures
Statistical analysis was performed using the Graph Pad Prism
Software (San Diego, CA, USA). Comparisons between values of
different groups were performed using one-way ANOVA.
Significance was determined using Tukey’s multiple comparison
tests for unequal replicates or Student t Test. All values presented
in this study represent means 6 SEM. Differences between means
were considered significant when p was 0.05 or less.
Results
LPS-induced PGE2 and PGF2a Production is Mediated by
Endocannabinoids
As mentioned before, previous results showed that in vivo
administration of LPS increased PGE2 and PGF2a production in
the uterus of early pregnant mice [1]. Figure 1 (A and B) shows
that uterine explants incubated for 24 h in the presence of LPS
(1 mg/ml) induced PGE2 and PGF2a production in vitro. To
evaluate whether endogenous cannabinoids could modify LPS-
induced PG production, uterine explants were incubated for 24 h
in the presence of LPS (1 mg/ml), LPS plus AM251 (CB1 receptor
antagonist) or LPS plus SR144528 (CB2 receptor antagonist) and
PGE2 and PGF2a levels were assessed by RIA. LPS-induced PGE2
synthesis was observed to be significantly increased when uterine
Figure 5. LPS-induced COX-2 activity is mediated by endocannabinoids. Uterine explants were incubated with LPS alone (1 ug/ml), LPS
plus AM251 (10 nM) or LPS plus SR144528 (10 nM) for 24 h and COX-2 enzyme activity was determined by measuring the disappearance of the
radiolabelled substrate [14C]-AA. Enzyme activity is reported as nmol of disappeared [14C]-AA/mg protein/h. ANOVA test. a, p,0.001 vs control; b,
p,0.01 vs control; c, p,0.001 vs LPS; n = 4.
doi:10.1371/journal.pone.0039532.g005
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explants were incubated with LPS and AM251 (10 nM)
(Figure 1A). Nevertheless, incubation of the endotoxin with the
CB2 receptor antagonist (10 nM) had no effect on PGE2 increased
levels due to LPS in the same tissue (Figure 1A). Higher
concentrations of the CB2 receptor antagonist were also used
with the same results (data not shown). On the other hand, LPS-
induced PGF2a synthesis was partially but significantly decreased
when uterine explants were incubated both with LPS and AM251
(10 nM) or with LPS and SR144528 (100 nM) (Figure 1B). PG
levels remained unchanged when tissues were incubated either
with AM251 or SR144528 alone. These findings suggest that
endocannabinoids could exert opposite effects on PGE2 and
PGF2a biosynthesis, by inhibiting PGE2 production and increasing
PGF2a levels.
Among endocannabinoids AEA has been reported to regulate
PG production in several tissues [12,13]. Mitchell et al. have shown
that AEA significantly reduced PGE2 production in human
decidual tissue [11]; on the other hand, Someya et al. showed
that AEA stimulates PGF2a formation in PC12 cells [13].
Regarding LPS-induced PG production is mediated by endocan-
nabinoids and considering that AEA could be involved in this
process, we next analyzed if exogenous AEA could modify PG
biosynthesis. First, uterine explants were incubated with metha-
nandamide (m-AEA, a stable synthetic AEA analog) and PGE2
and PGF2a levels were determined by RIA. We observed that
explants incubated with m-AEA 100 nM showed a significantly
increase of PGF2a levels (Figure 2B), while PGE2 levels were
significantly reduced (Figure 2A). We also used an inhibitor of
AEA degradation (URB597, 1 uM) with the same results
(Figure 2A and B). To test whether AEA mediates LPS-induced
PG production, uterus was incubated in the presence of LPS
(1 mg/ml) plus m-AEA (100 nM) or LPS (1 mg/ml) plus URB597
(1 uM) for 24 h and PG levels were assessed by RIA. Figure 2A
shows that PGE2 production induced by LPS was partially but
significantly decreased when tissues were incubated either with
LPS plus m-AEA or with LPS plus URB597. On the other hand,
PGF2a production was significantly increased when tissues were
incubated with LPS plus m-AEA (figure 2B).
Effect of LPS on CB1 and CB2 mRNA and Protein Levels
The data showed in figure 1 suggest a possible involvement of
CB1 and CB2 on PG production upon stimulation with LPS. In
Figure 6. Effect of AEA on COX-2 expression. Densitometric analysis of A) mRNA and B) protein expression of COXs. Uterine explants were
incubated without/with m-AEA (100 nM) for 24 h. Student t test. a, p,0.05 vs control; b, p,0.001 vs control. n = 4. One representative gel/blot is
shown.
doi:10.1371/journal.pone.0039532.g006
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order to determine the effect of LPS on CB1 and CB2 expression
in uterine explants, tissues were incubated for 24 h in the
presence of LPS (1 mg/ml) and mRNA and protein levels were
assessed. We observed the presence of both CB receptors, CB1
and CB2, in pregnant murine uterus. Furthermore, our results
show that the endotoxin caused an increase in CB1 expression
(Figure 3A and B) while CB2 levels remained unchanged
(Figure 3C and D).
LPS-induced PG Synthesis and Cyclooxygenase (COX)
Expression is Mediated by Endocannabinoids
Since PG synthesis first involves the release of arachidonic acid
which is converted to prostaglandin H2 (PGH2) by cyclooxygenase
1 (COX-1) or cyclooxygenase 2 (COX-2) enzymes, uterine
explants were incubated for 24 h in the presence of LPS (1 ug/
ml) alone, LPS plus AM251 (10 nM) or LPS plus SR144528
(100 nM) and COX-1 and COX-2 mRNA and protein levels were
assessed. RT-PCR and western-blot analysis indicated that LPS
significantly increased the expression of COX-2, whereas COX-1
mRNA and protein levels remained unchanged (Figures 4A and
B). On the other hand, LPS-induced COX-2 expression (both
mRNA and protein) was observed to be partially but significantly
decreased when uterine explants were incubated either with LPS
and AM251 or with LPS and SR144528 (Figure 4A and B). COX
Figure 7. AEA increases COX-2 activity. Uterine explants were
incubated with m-AEA (100 nM) or URB597 (1 uM) for 24 h and COX-2
enzyme activity was determined by measuring the disappearance of the
radiolabelled substrate [14C]-AA. Enzyme activity is reported as nmol of
disappeared [14C]-AA/mg protein/h. ANOVA test. a, p,0.05 vs control;
b, p,0.01 vs control; n = 4.
doi:10.1371/journal.pone.0039532.g007
Figure 8. Endocannabinoids modulate mPGES-1 mRNA levels. Densitometric analysis and mRNA expression of PGES isoforms. Uterine
explants were incubated with LPS alone (1 ug/ml), LPS plus AM251 (10 nM) or LPS plus SR144528 (10 nM) for 24 h. A) One representative gel is
shown. B) Densitometric analysis. ANOVA test. a, p,0.001 vs control; b, p,0.01 vs LPS; c, p,0.001 vs LPS. n = 5.
doi:10.1371/journal.pone.0039532.g008
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levels remained unchanged when tissues were incubated with
AM251 or SR144528 alone (data not shown).
Regarding these results, we next evaluated COX-2 activity by
measuring the disappearance of the radiolabelled substrate [14C]-
arachidonic acid. Figure 5 shows a 3-fold increase in COX-2
activity when tissues were incubated with LPS alone. Moreover,
LPS-induced COX-2 activity was partially but significantly
decreased when uterine explants were incubated either with LPS
and AM251 or with LPS and SR144528. These findings suggest
that endocannabinoids mediate LPS-induced COX-2 activity.
As stated before, several lines of evidence indicate that both,
cannabinoids and AEA, stimulate arachidonic acid (AA) release in
several tissues [14,15,16]. Thus, we next analyzed if exogenous
AEA could modify COX-1 and COX-2 mRNA and protein levels.
RT-PCR and western-blot analysis indicated that m-AEA
significantly increased the expression of COX-2, whereas COX-
1 mRNA and protein levels remained unchanged (Figures 6A and
B). We next evaluated COX-2 activity. Figure 7 shows a 2-fold
increase in COX-2 activity when tissues were incubated either
with m-AEA (100 nM) or URB597 (1 uM) alone. These results
suggest that AEA could be mediating, at least partially, LPS-
induced COX-2 activity.
AEA: a Possible Role in PGE2 Metabolism
Our data show that AEA-induced PGF2a production correlates
with the increased expression and activity of COX-2. Neverthe-
less, decreased production of PGE2 induced by AEA is not
explained by an augmentation of COX-2 expression and activity.
In this sense, PGE2 levels could fluctuate due to inhibition of its
synthesis, an increased catabolism or both. PGE2 synthesis
involves the activity of PGE synthase (PGES) which catalyzes
conversion of COX-derived PGH2 to PGE2. So far, three different
isoforms have been identified with the capacity to synthesize PGE2
[26]. These include membrane-associated (or microsomal) PGE2
synthase-1 and –2 (mPGES-1 and mPGES-2, respectively), and
Figure 9. Endocannabinoids modulate mPGES-1 protein levels. Densitometric analysis and protein expression of mPGES-1. Uterine explants
were incubated with LPS alone (1 ug/ml), LPS plus AM251 (10 nM) or LPS plus SR144528 (10 nM) for 24 h. ANOVA test. a, p,0.001 vs control; b,
p,0.001 vs LPS; c, p,0.01 vs LPS. n = 4.
doi:10.1371/journal.pone.0039532.g009
Figure 10. AEA decreases mPGES-1 mRNA and protein levels.
Densitometric analysis of A) mRNA and B) protein expression of mPGES-
1. Uterine explants were incubated without/with m-AEA (100 nM) for
24 h. Student t test. a, p,0.05 vs control; b, p,0.001 vs control. n = 5.
One representative gel/blot is shown.
doi:10.1371/journal.pone.0039532.g010
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cytosolic PGES (cPGES). Regarding this evidence, we first
investigate whether endogenous cannabinoids could modify the
expression of these enzymes and thus, we evaluated the effect of
LPS plus CB receptor antagonists on uterine mRNA levels of
PGES isoforms. Our results show that only mPGES-1 mRNA
levels were significantly increased when uterine explants were
incubated in the presence of LPS (Figure 8B). Moreover, LPS-
induced mPGES-1 expression was observed to be significantly
increased when uterine explants were incubated with LPS and
AM251 (10 nM) or with LPS and the CB2 receptor antagonist
(100 nM) (Figure 8B). We next evaluated if endocannabinoids
could modulate mPGES-1 protein levels. Western blot analysis
showed that LPS-induced mPGES-1 expression was significantly
increased when tissues were incubated with LPS plus CB receptor
antagonists (Figure 9).
As we mentioned before, AEA reduces PGE2 production in
human decidual tissue [11]. Considering that LPS-induced
mPGES-1 expression is mediated by endocannabinoids and
regarding AEA could be involved in this process, we next
analyzed if exogenous AEA could modify the expression of
mPGES-1. Our results show that both mPGES-1 mRNA and
protein levels were significantly reduced when uterine explants
were incubated in the presence of m-AEA (100 nM) (Figure 10A
and B, respectively).
Regarding the very small decline in mPGES-1 mRNA (although
significant) and the substantial decrease in mPGES-1 protein we
decided to make a more quantitative approach by performing
a real time PCR at early times. We assessed mPGES-1 mRNA
levels when uterine explants were incubated either for 3 h or 6 h
in the presence of m-AEA (100 nM). We observed that mPGES-1
mRNA levels remained unchanged after 3 h incubation in the
presence of m-AEA. Nevertheless, uterine explants incubated for
6 h in the presence of the synthetic analog reduced mPGES-1
mRNA levels up to nearly 25% (Figure 11).
We next investigate whether exogenous AEA could modify the
production of PGE2 by modulating PGES activity. Thus, uterine
explants were incubated in the presence of m-AEA (100 nM) alone
or m-AEA plus indomethacin (INDO 1 mM [27], a non-selective
COX inhibitor) and conversion of PGH2 to PGE2 was assessed by
RIA. Incubation with INDO prevents COX-derived PGE2 de novo
synthesis from AA release. We observed that m-AEA significantly
decreased PGES activity (Figure 12). These findings suggest that
AEA could be downregulating uterine PGE2 levels by inhibiting its
synthesis.
Another enzyme which may influence the level and biological
activity of PGs is 15-hydroxyprostaglandin dehydrogenase (15-
PGDH). It is responsible for converting PGs into biologically
inactive 15-keto derivative [28]. We first studied the effect of AEA
on 15-PGDH mRNA and protein levels in uterine explants
incubated with m-AEA 100 nM for 24 h. RT-PCR and western-
blot analysis indicated that m-AEA did not modify 15-PGDH
expression (data not shown). Next, we studied whether AEA could
modify the production of PGE2 metabolite (PGEM, biologically
inactive). In this sense, PGEM quantification was assessed in
culture supernatants by Cayman’s PGE metabolite EIA kit as
described in the Materials and methods section. At the same time,
PGE2 levels were assessed in the same sample by RIA. Our results
Figure 11. Quantitative real-time PCR analysis of mPGES-1 expression. Uterine explants were incubated without/with m-AEA (100 nM) for
3 h and 6 h and then subjected to qPCR analysis. Data was normalized against b-actin and mPGES-1 mRNA levels under control conditions (no m-
AEA) were set to 1 (dotted line). Experiments were independently run three times. In each experiment, cDNA samples were performed in triplicate.
Student t Test. a, p,0.05 vs control. n = 9.
doi:10.1371/journal.pone.0039532.g011
Figure 12. Effect of AEA on PGE synthase activity. Uterine
explants were incubated with m-AEA (100 nM), INDO (1 mM) or m-AEA
plus INDO for 24 h. Results were expressed as pg PGE2/mg protein/h.
ANOVA Test. a, p,0.001 vs control or INDO. n = 4. PGE2 levels were
assessed by RIA.
doi:10.1371/journal.pone.0039532.g012
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show that m-AEA (100 nM) significantly decreased PGE2 levels
corroborating the results showed before, and at the same time,
significantly increased PGEM production in the same samples
(Figure 13).
In several tissues, including deciduas and fetal membranes,
PGE2-9-ketoreductase (9-KPR) converts PGE2 into PGF2a thus
regulating PGE2/PGF2a ratio in these tissues [29,30]. Therefore,
we studied the effect of AEA on 9-KPR activity in uterine explants
incubated with m-AEA 100 nM for 24 h. We found that although
we detected 9-KPR activity in the uterus of pregnant mice m-AEA
did not modify it in this tissue (data not shown).
These findings suggest a possible role of AEA on PGE2
metabolism and, in this sense, AEA could be downregulating
uterine PGE2 levels not only by inhibiting its synthesis but also by
increasing its degradation.
Discussion
Embryonic resorption induced by sepsis is viewed as a serious
obstetric problem but it may also be seen from an evolutionary
perspective as a pathophysiological mechanism to protect the
maternal reproductive potential by expelling infected material.
Prostaglandins are potent stimulators of myometrial contractility
[31] and are used clinically to induce abortion and stimulate
parturition [4]. Particularly, both PGE2 and PGF2a stimulate
myometrial contractility and are produced during labor by
gestational tissues [32,33]. Our previous results showed that in
vivo administration of LPS increased PGE2 and PGF2a production
in the uterus of early pregnant mice. Also, we have observed that,
in mice challenge with LPS, the in vivo administration of COX
inhibitors prevented LPS-induced ER [1]. Collectively, these data
suggest that although PGs are important paracrine regulators of
uterine function in normal pregnancies, in an inflammatory setting
such as sepsis, PGs have deleterious effects.
On the other hand, several lines of evidence show that LPS
increases AEA levels [8,9] and also that AEA modulates
prostaglandin production in different tissues [11,12,13].
Based on the above evidence, we hypothesized that LPS-
induced PG synthesis is mediated by endocannabinoids. Our
results showed that endocannabinoids are involved in LPS-
induced PG biosynthesis and also had different effects on PG
biosynthetic pathways. While LPS-induced PGF2a production was
partially abrogated through both CB1 and CB2 receptors, LPS-
induced PGE2 production was significantly increased when uterine
explants were incubated with LPS plus a selective CB1 inhibitor
(AM251) compared to explants incubated with LPS alone. On the
other hand, CB2 receptor appeared not to be involved in LPS-
induced PGE2 production. Considering that other groups’ findings
show that, among endocannabinoids, AEA modulates PG bio-
synthetic pathways differently [11,12,13] we next evaluated
whether AEA mediates LPS-induced PG production. Thus, we
assessed uterine PGE2 and PGF2a production in the presence of
LPS plus a stable synthetic analog of AEA called m-AEA, or LPS
plus an inhibitor of AEA degradation, URB597. Our findings
showed that PGE2 production induced by LPS was partially but
significantly decreased when tissues were incubated either with
LPS plus m-AEA or with LPS plus URB597. On the other hand,
PGF2a production was significantly increased when tissues were
incubated with LPS plus m-AEA. Together, these results suggest
that AEA may be involved in LPS-induced PG production and
that it modulates PG biosynthetic pathways differently for each
PG. This is in accordance with the findings from other groups
where it has been reported that AEA stimulates PGF2a formation
in PC12 cells [13] and also exerts a significant reduction in PGE2
production in human decidual tissue [11]. We have also shown
that endocannabinoids mediate LPS-induced COX-2 activity,
mRNA and protein expression and AEA could be involved in this
process. Although we showed that mAEA had opposite effects on
PGE2 and PGF2a production, our previous results demonstrate
that LPS induced the increase of PGs both in vivo [1] and in vitro.
Also, LPS-induced COX-2 activity and expression was partially
but significantly decreased when tissues were incubated with LPS
and CB receptor antagonists. Taking this into consideration, it
seems that AEA partially mediates LPS-induced PG production
and therefore, we cannot rule out that other mechanisms (and/or
other endocannabinoids) may be involved in this process.
On the other hand, we detected CB1 expression in the uterus of
pregnant mice and also we reported for the first time the presence
of CB2 in this tissue, contrary to other groups’ findings that suggest
the absence of CB2 both in the oviduct and in the uterus of mice
[34,35]. Moreover, we have shown that LPS modulated CB1
mRNA and protein expression although CB2 levels remained
unchanged. This is in accordance with the work of Matias et al.
[36] and Do et al. [37] where they reported that LPS modulates
CB1 and CB2 expression in dendritic cells.
Taking into consideration that AEA-induced PGF2a production
correlates with an increased expression and activity of COX-2 but
decreased production of PGE2 induced by AEA is not in
accordance with the regulation of COX-2 levels, we investigated
whether endogenous cannabinoids could modify the expression of
Figure 13. AEA augments PGE2 metabolite levels. Uterine explants were incubated without/with m-AEA (100 nM) for 24 h. A) PGE2 production
assessed by RIA; B) PGEM quantification assessed by PGE metabolite EIA kit. Student t Test. a, p,0.001 vs control; b, p,0.01 vs control. n = 5. Both
metabolites were assessed in the same sample. PGEM, Prostaglandin E2 metabolite.
doi:10.1371/journal.pone.0039532.g013
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the three different isoforms with capacity to synthesize PGE2
identified so far, m-PGES-1, mPGES-2 and cPGES. Our results
showed that only mPGES-1 expression was induced in the
presence of LPS. This is in accordance with previous reports
where a preferential coupling of COX-2 with mPGES-1 is shown
in infectious response [38] and their expression is induced by pro-
inflammatory mediators [23]. Moreover, LPS-induced mPGES-1
expression was observed to be significantly increased when uterine
explants were incubated with LPS and CB receptor antagonists
suggesting the participation of endocannabinoids in this process.
We also investigated the effect of exogenous AEA on different
steps of PGE2 metabolic pathway. Our results showed that AEA
downregulated PGE2 levels most likely due to inhibition of its
synthesis and upregulation of its degradation. We have observed
that AEA significantly reduced mPGES-1 mRNA and protein
levels, which probably contribute to the decrease of PGE2
synthesis. These results are in accordance with Navarrete et al.
[39] who reported that N-arachidonoyldopamine (NADA, another
member of the endocannabinoid family) is a potent inhibitor of
PGE2 production through a mechanism that involves reduction in
the synthesis of mPGES-1 protein in LPS-activated microglia.
Taking this evidence into consideration we cannot rule out that
other endogenous CB1 and CB2 agonists (such as NADA and 2-
AG, 2-arachidonoyl-glycerol) could also be involved in the action
of LPS. The fact that AEA reduces PGE2 levels could be
considered as an anti-inflammatory effect of this endocannabinoid.
On the other hand, although several groups have reported that
uterine 15-PGDH activity is regulated by progesterone during the
entire pregnancy [40,41] this is the first time that an endocanna-
binoid modulation of PGE2 degradation is demonstrated.
The above reported data and our previous results [1] show that
LPS induces PGE2 and PGF2a production. Nevertheless, it is
possible that PGE2/PGF2a ratio more than the concentration
reached by each of these PGs, may play a critical role in many
biological functions, such as contractility. In fact, the altered ratio
of PGE2/PGF2a was described as one of the factors involved in the
retention of fetal membranes in cattle [42,43,44]. In our case,
where we studied PGE2 and PGF2a participation in LPS-induced
embryonic resorption [1] there always seemed to be a pre-
dominance of PGF2a over PGE2. The difference in the amount of
PGF2a and PGE2 that reaches the uterus may play a role in the
control of myometrial contractility. PGF2a mediates myometrial
contractions associated with the onset of labor [32]. Although it is
less clearly established, PGE2 is thought to exert the opposite
action and favor the establishment of pregnancy. Moreover, Slater
et al. [45] have reported that PGE2 has anti-inflammatory and
relaxatory effects on human myometrial smooth muscle.
Other groups have shown that LPS increases AEA production
[8,9] and in spite of the fact that we did not measure direct
changes in endocannabinoid concentrations in culture media after
LPS challenge, the use of CB specific antagonists and the use of m-
AEA allow us to hypothesized that AEA could be involved in the
mechanisms implicated in LPS-induced embryonic resorption. We
propose that AEA participates in LPS-induced COX-2 expression
and activity, increasing PGF2a levels and downregulating PGE2
production modulating PG’s ratio in this tissue. AEA inhibitory
effect on PGE2 production may be compensated by LPS stimulus
(which may involve other endogenous CB receptor agonists and/
or other mechanisms) and the final outcome is likely to be a PGE2/
PGF2a ratio that would favor myometrial contractions which in
turn contribute to fetal expulsion in an inflammatory setting.
In conclusion, this study suggests that AEA acts as a pro-
contractility agent modulating the production of PGs induced by
LPS. This and our previous results showing that AEA participates
in the increase of nitric oxide synthesis induced by LPS [10]
demonstrate that this endocannabinoid could contribute to the
mechanisms associated with pathological reproductive events such
as septic abortion.
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